You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 5, 2025

Drug Price Trends for DESMOPRESSIN AC


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for DESMOPRESSIN AC

Average Pharmacy Cost for DESMOPRESSIN AC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
DESMOPRESSIN AC 4 MCG/ML VIAL 65219-0293-01 21.84580 ML 2024-12-18
DESMOPRESSIN ACETATE 0.2 MG TB 69918-0201-01 0.40552 EACH 2024-12-18
DESMOPRESSIN AC 4 MCG/ML VIAL 25021-0460-01 21.84580 ML 2024-12-18
DESMOPRESSIN AC 4 MCG/ML VIAL 70860-0454-01 21.84580 ML 2024-12-18
DESMOPRESSIN AC 4 MCG/ML VIAL 70095-0026-02 21.84580 ML 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for DESMOPRESSIN AC

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
DESMOPRESSIN ACETATE 0.1MG/ML SOLN,NASAL SPRA Golden State Medical Supply, Inc. 60505-0815-00 5ML 19.10 3.82000 ML 2023-06-15 - 2028-06-14 FSS
DESMOPRESSIN ACETATE 4MCG/ML INJ,AMP,1ML Dr. Reddys Laboratories 43598-0931-09 10x1ML 283.42 2021-09-16 - 2025-09-14 FSS
DDAVP 4MCG/ML INJ Ferring Pharmaceuticals, Inc. 55566-2300-00 1 511.90 511.90000 EACH 2020-06-01 - 2025-05-31 FSS
DDAVP 10MCG/SPRAY NASAL SPRAY Ferring Pharmaceuticals, Inc. 55566-2500-00 1 327.64 327.64000 EACH 2020-06-01 - 2025-05-31 Big4
DDAVP 4MCG/ML INJ Ferring Pharmaceuticals, Inc. 55566-2200-00 10X1ML 505.60 2022-01-01 - 2025-05-31 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

DESMOPRESSIN AC Market Analysis and Financial Projection

Desmopressin Market Analysis and Price Projections

Market Overview

Desmopressin, a synthetic analogue of the natural hormone vasopressin, is widely used to treat various medical conditions including diabetes insipidus, nocturnal enuresis, hemophilia A, and von Willebrand disease. The global desmopressin market is experiencing significant growth driven by several key factors.

Market Size and Growth

As of 2022, the global desmopressin market was valued at USD 1,055.63 million and is projected to grow to USD 1,657.28 million by 2030, with a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period of 2023-2030[1].

Another projection suggests that the market size could reach USD 1,647.4 million by 2031, growing at a CAGR of 5.3% from 2024 to 2031[2].

Drivers of Market Growth

Growing Prevalence of Diabetes and Other Conditions

The increasing incidence of diabetes insipidus, nocturnal polyuria, and other conditions treated by desmopressin is a major driver of the market. The global prevalence of diabetes has risen significantly, from 108 million in 1980 to 422 million in 2014, particularly in low and middle-income countries[1].

Improvements in Drug Delivery Systems

Advancements in drug delivery systems, such as sublingual tablets and nasal sprays, have enhanced the effectiveness and convenience of administering desmopressin. These improvements have boosted patient compliance and expanded treatment options, contributing to market growth[2].

Increasing Awareness and Healthcare Expenditure

Increased awareness about the conditions treated by desmopressin, along with rising healthcare expenditure, especially in developing nations, has made these drugs more accessible. This has led to a higher demand for desmopressin-containing medications[1][2].

Market Segmentation

By Form

The desmopressin market is segmented by form into injectable solutions, nasal sprays, and tablets. Each form has its own set of advantages and is preferred based on the specific condition being treated and patient compliance.

By Applications

The market is segmented by applications into pediatric use and geriatric use. The increasing incidence of bedwetting episodes in children and the need for effective treatments in geriatric populations drive demand in these segments[1].

By End-Users

The market is segmented by end-users into hospitals, homecare, specialty clinics, and others. Hospitals and homecare settings are significant segments due to the widespread use of desmopressin in these environments[1].

By Distribution Channel

The distribution channels include hospital pharmacies, online pharmacies, and retail pharmacies. The convenience and accessibility offered by online pharmacies are expected to contribute to market growth[1].

Regional Analysis

North America

North America dominates the desmopressin market due to the presence of key manufacturers and high levels of research and development activities. The United States and Canada are leading markets in this region[2][4].

Asia-Pacific

The Asia-Pacific region is expected to experience the highest growth during the forecast period, driven by new research and developments in the desmopressin market. Countries like India, China, and Japan are significant contributors to this growth[1][2].

Challenges and Restraints

Side-Effects and Complications

Desmopressin can cause side-effects such as flushing, nausea, transient headache, and mild abdominal cramps, especially with heavy dosages. These complications can hamper market growth[1].

Low Awareness and Diagnosis

The commercial potential of desmopressin is restricted by the low awareness and underdiagnosis of the conditions it treats among patients and healthcare professionals[2].

Price Sensitivity and Supply Disruptions

Pricing demands from healthcare payers and potential supply disruptions can impact the affordability and accessibility of desmopressin products, affecting market demand[2].

Price Projections and Affordability

Current Pricing

The cost of desmopressin varies by form:

  • Injectable solution: Around $163 for a 10 milliliter supply[5].
  • Nasal spray: Starting from $88.30 for 5 milliliters[5].
  • Oral tablets: Starting from $41.10 for 30 tablets (0.1 mg) and $52.74 for 30 tablets (0.2 mg)[5].

Discounts and Patient Assistance

Discount cards and patient assistance programs can significantly reduce the cost of desmopressin, making it more affordable for patients. For example, the Drugs.com Discount Card can save up to 80% on prescription medicines[5].

Key Takeaways

  • The global desmopressin market is projected to grow significantly, driven by increasing prevalence of treated conditions and improvements in drug delivery systems.
  • North America and Asia-Pacific are key regions contributing to market growth.
  • Side-effects, low awareness, and price sensitivity are significant challenges.
  • Patient assistance programs and discounts can enhance affordability.

FAQs

1. What is the primary use of desmopressin?

Desmopressin is primarily used to treat conditions such as diabetes insipidus, nocturnal enuresis, hemophilia A, and von Willebrand disease.

2. What is the projected market size of desmopressin by 2030?

The global desmopressin market is projected to reach USD 1,657.28 million by 2030[1].

3. Which region is expected to experience the highest growth in the desmopressin market?

The Asia-Pacific region is expected to experience the highest growth during the forecast period due to new research and developments[1][2].

4. What are the common forms of desmopressin available?

Desmopressin is available in injectable solutions, nasal sprays, and oral tablets[1].

5. How can patients reduce the cost of desmopressin?

Patients can use discount cards and patient assistance programs to reduce the cost of desmopressin, potentially saving up to 80% on prescription medicines[5].

Sources:

  1. Data Bridge Market Research - Global Desmopressin Market Size, Outlook, Trends, Report | Forecast 2030
  2. Verified Market Research - In-Depth Industry Outlook: Desmopressin Market Size & Forecast
  3. Wicz - Desmopressin Market Growth Dynamics 2024: Global Opportunity Analysis by 2032
  4. Biospace - Desmopressin Acetate Market: Rising prevalence of diabetes to drive the market
  5. Drugs.com - Desmopressin Prices, Coupons, Copay Cards & Patient Assistance

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.